Guggenheim lowered the firm’s price target on Accenture (ACN) to $285 from $305 and keeps a Buy rating on the shares. While Accenture’s fiscal Q4 revenue growth came in toward the high end of its guidance range and management provided a FY26 outlook consistent with expectations, they “did little to assuage the prevailing investor bear thesis on the potential for ongoing margin challenges,” the analyst says. A restructuring in the quarter likely provides bears with tactical data points on a potential lack of durability in management’s profitability algorithm given ongoing gross margin challenges and the fact that this marks the company’s second restructuring in three years, the analyst added.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACN:
- Accenture price target lowered to $290 from $302 at JPMorgan
- Accenture’s Balanced Outlook: Hold Rating Amid Growth Opportunities and Challenges
- Accenture’s Earnings Call: AI Growth and Financial Strength
- Positive Long-Term Outlook for Accenture Amid Challenges and Strategic Growth Initiatives
- Accenture price target lowered to $270 from $325 at BMO Capital
